Semaglutide is emerging as a promising treatment for obesity and type two diabetes. It mimics a natural hormone to regulate blood sugar and appetite, leading to significant weight loss. Studies show patients can lose over 20% of their weight, rivaling bariatric surgery. While it may lower heart attack and stroke risks, its high cost and side effects raise concerns about accessibility and safety.